US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Hapvida Participacoes E Investimentos SA (PK) (HAPVY) 銘柄情報

Hapvida Participacoes E Investimentos SA (PK) (HAPVY)

2.23

0.00

(0.00%)

終了 7月9日 5:00AM

Hapvida Participacoes E Investimentos SA (PK) (HAPVY) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.23

( - )

買値

2.23

売値

2.23

出来高

-

平均取引量 (3 か月)

US$ 9,018,561

財務取引量

-

0.00 日の範囲 0.00

2.23 52 週間の範囲 3.3291

時価総額

企業価値

12.936B

前日終値

2.23

始値

-

時刻

最終取引時間

VWAP

-

歳入

31.85B

純利益

-428.85M

発行済株式数

475,060,139

浮動株比率 (%)

49.39%

機関投資家保有比率 (%)

41.99%

配当利回り

PER

-12.3

株価売上高倍率 (PSR)

0.16

1 株当たり利益 (EPS)

-0.86

ベータ

0.31

Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. It sells health insurance plans through its own clinical, outpatient, and hospital networks, as well as dental plans through an accredited network. Hapvida Participações e Investi... Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. It sells health insurance plans through its own clinical, outpatient, and hospital networks, as well as dental plans through an accredited network. Hapvida Participações e Investimentos S.A. was founded in 1979 and is headquartered in Fortaleza, Brazil. 詳細を表示

セクター

Finance

業界

Insurance

ウェブサイト

ri.hapvida.com.br

本社

Fortaleza, Brazil

設立

1979

Hapvida Participacoes E Investimentos SA (PK) is listed in the Finance sector of the その他OTC with ticker HAPVY. The last closing price for Hapvida Participacoes E ... (PK) was US$2.23. Over the last year, Hapvida Participacoes E ... (PK) shares have traded in a share price range of US$ 2.23 to US$ 3.3291.

Hapvida Participacoes E ... (PK) currently has 475,060,139 shares in issue. The market capitalisation of Hapvida Participacoes E ... (PK) is US$1.06 billion. Hapvida Participacoes E ... (PK) has a price to earnings ratio (PE ratio) of -12.30.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	-1.0991	-33.0149289598	3.3291	3.3291	2.23	500	2.23	DR
26	-1.0991	-33.0149289598	3.3291	3.3291	2.23	286	2.23	DR
52	-0.44	-16.4794007491	2.67	3.3291	2.23	105	2.23	DR
156	-0.44	-16.4794007491	2.67	3.3291	2.23	492	2.58863153	DR
260	-0.44	-16.4794007491	2.67	3.3291	2.23	492	2.58863153	DR

HAPVY - Frequently Asked Questions (FAQ)

What is the current Hapvida Participacoes E Investimentos SA (PK) share price?

The current share price of Hapvida Participacoes E Investimentos SA (PK) is US$ 2.23

How many Hapvida Participacoes E Investimentos SA (PK) shares are in issue?

Hapvida Participacoes E Investimentos SA (PK) has 475,060,139 shares in issue

What is the market cap of Hapvida Participacoes E Investimentos SA (PK)?

The market capitalisation of Hapvida Participacoes E Investimentos SA (PK) is USD 1.06B

What is the 1 year trading range for Hapvida Participacoes E Investimentos SA (PK) share price?

Hapvida Participacoes E Investimentos SA (PK) has traded in the range of US$ 2.23 to US$ 3.3291 during the past year

What is the PE ratio of Hapvida Participacoes E Investimentos SA (PK)?

The price to earnings ratio of Hapvida Participacoes E Investimentos SA (PK) is -12.3

What is the cash to sales ratio of Hapvida Participacoes E Investimentos SA (PK)?

The cash to sales ratio of Hapvida Participacoes E Investimentos SA (PK) is 0.16

What is the registered address of Hapvida Participacoes E Investimentos SA (PK)?

The registered address for Hapvida Participacoes E Investimentos SA (PK) is Av. Heráclito Graça, no. 406, Fortaleza, Ceará

What is the Hapvida Participacoes E Investimentos SA (PK) website address?

The website address for Hapvida Participacoes E Investimentos SA (PK) is ri.hapvida.com.br

Which industry sector does Hapvida Participacoes E Investimentos SA (PK) operate in?

Hapvida Participacoes E Investimentos SA (PK) operates in the Insurance sector

ORCA

LION LOB.SEND THIS TO $BCDS.AS TO WHY $SRXH RUN YESTERDAY 150% FROM LOW OF .96 TO $2.50 WITHIN AN HOUR.
THEY HAD TWO PRs YESTERDAY. ONE WAS A CASH DIVY OF .05 PER SHARE.READ THE NEWS BELOW.
AND THE PR NUMBER 2 WAS TALKING ABOUT THE NET ASSET VALUE.OF $3.07 PER SHARE.CASH ETC.

iHub News

iHub News 11分前

Wall Street Futures Edge Higher as U.S.-Iran Conflict Escalates and PepsiCo Earnings Loom: Dow Jones, S&P, NasdaqJuly 9, 2026 5:53 AM
IH Market News

sctts

$$$ Today is the Day $$$$

$$$SFRX$

JamesF1

JamesF1 12分前

Interesting article Sharkey. So far, Cardinal has been supplying Eliquis to the stores I work without interruption. I am working an evening shift later today. I will double check if any change since Monday (the last day I worked).

JamesF1

JamesF1 17分前

Hi mrwrn2010, both Vyvanse generic and Adderall generic have been mostly available from Cardinal from at least one manufacturer. The exception lately has been Adderall XR 30mg generic. That particular strength has been out from all manufacturers intermittently. Elite is no longer the cheapest Vy

rakp

Thanks, but it won't let me sign in or set up an account.
Can you pls tell me in a nutshell what it says?

brazen22

brazen22 29分前

Yes, I think you did miss something.

I was responding to your own point that Bosch’s PSM presentation is not intended to replace what was already submitted to MHRA, but is more about supporting a future peer-reviewed PSM paper for future FDA, EU, Canada, and other filings.

US Market News

US Market News 41分前

Vision Marine Technologies Enters Agreement to Sell 1400 S. Federal and Advances Florida Real Estate Optimization Supporting Approximately US$13.1 Million in Gross Proceeds, US$5.6 Million in Estimated Net Equity and US$3.5 Million in Annualized Cost ReducJuly 9, 2026 5:15 AM
PR Newsw

vuletini

vuletini 54分前

Business model is collapsing. RLUSD will cannibalize XRP other stablecoins will kill it.
Long term I see .30 never to reach $1 again.... You can kiss the baby

gregcod

gregcod 55分前

Im expecting that IBATs pps will be .20 to .3 in the month of August..Just an opinon..so much horizontal chart movements..We have a bottom here..

US Market News

US Market News 56分前

Sky Quarry Appoints Refining Industry Veteran Ray Hansen as President of Foreland Refining CorporationJuly 9, 2026 5:00 AM
ACCESS NewswireFormer HF Sinclair executive brings more than 35 years of refinery operations, engineering, and leadership experience to support the

new-stocks

new-stocks 58分前

https://getmysocial.com/tina9

new-stocks

new-stocks 58分前

https://getmysocial.com/tina9

new-stocks

new-stocks 58分前

https://getmysocial.com/tina9

new-stocks

new-stocks 59分前

https://getmysocial.com/tina9

new-stocks

new-stocks 59分前

https://getmysocial.com/tina9

new-stocks

new-stocks 1時間前

https://getmysocial.com/tina9

Sideem

Sideem 1時間前

I asked ChatGPT the following:

"Why is BBUL shares selling for almost twice the price of regular BB shares?"

This catches a lot of people by surprise, but the price of BBUL is not supposed to equal—or even be close to—the price of BB stock.

The ETF sponso

new-stocks

new-stocks 1時間前

https://linktw.in/UQjike

new-stocks

new-stocks 1時間前

https://linktw.in/UQjike

new-stocks

new-stocks 1時間前

https://linktw.in/UQjike

JRyan

JRyan 1時間前

Is ZNOG A Good Investment? An Honest Assessment

https://i.postimg.cc/dV8XpJmX/New-To-ZNOG-Fig1-License-Map.jpg
(Figure 1. The Megiddo-Jezreel License — the single asset on which this entire company depends. ~75,000 acres. License 434 base term expires September 13, 2026.)

north40000

north40000 1時間前

Substitute 9% for $19 Billion. ATTR-CM is the heart condition treated with other stabilizers that failed in Phase 3 trial. Has Vascepa been in clinical trials for that condition?

tkg

A good 2:13m video in link...

https://x.com/SanCompounding/status/2074871489476878370

new-stocks

new-stocks 1時間前

https://linktw.in/UQjike

Hapvida Participacoes E ... (PK)

Bond 3375% until June 15...

A91 Partners Fund Ii

Exchange Traded

Ceragon Networks

Scinai Immunotherapeutics

DJ Construction and Mate...

UBS MSCI EM ex China Soc...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。